Skip to content

Postherpetic Neuralgia: clinical trials and information

Neuropathic pain is pain caused by damage to, or disease of, the nervous system. People describe it with words such as burning, shooting, stabbing or electric. It can follow conditions such as diabetes, shingles, nerve injury or chemotherapy.
0
Trials with Canadian sites
0
Recruiting in Canada
10
Registry records worldwide

Postherpetic Neuralgia clinical trials in Canada

No registry record in this snapshot uses this exact term with a site in Canada. See related conditions below.

Postherpetic Neuralgia clinical trials worldwide (outside Canada)

10 trials, 3 recruiting or not yet recruiting. Recruiting first.

PhaseCountries
Simultaneous Engagement of Networks for Alleviating Pain (SENAP)
NCT07057206
Not yet recruitingPhase 1United StatesUniversity of Minnesota2026-11-01
Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic Neuralgia
NCT07390279
RecruitingTurkey (Türkiye)Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization2026-02-01
The Effectiveness of Ultra-Sound Guided Erector Spinae Block With Betamethasone for Management of Truncal Chronic Post Herpetic Neuralgia.
NCT07000409
RecruitingNot applicableEgyptCairo University2025-05-01
Combined Application of Pulsed RF and Steroids to the DRG for PHN
NCT05208918
CompletedNot applicableEgyptMansoura University2022-02-01
The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Paravertebral Block
NCT04876989
CompletedNot applicableSouth KoreaSeoul National University2021-07-21
Treatment of Chronic Postherpetic Pain With Autologous Fat Grafting - A RCT
NCT04099706
CompletedNot applicableDenmarkOdense University Hospital2019-09-19
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
NCT01688947
CompletedPhase 2United StatesPurdue Pharma LP2012-09
Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain
NCT01302275
CompletedPhase 4DenmarkSøren H. Sindrup2011-02
A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia
NCT01124617
CompletedPhase 2JapanJanssen Pharmaceutical K.K.2010-06
A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak
NCT00506610
WithdrawnPhase 2United StatesPfizer

About Postherpetic Neuralgia

What is Postherpetic Neuralgia?

Neuropathic pain is pain caused by damage to, or disease of, the nervous system. People describe it with words such as burning, shooting, stabbing or electric. It can follow conditions such as diabetes, shingles, nerve injury or chemotherapy.

How is Postherpetic Neuralgia usually assessed?

Clinicians usually assess neuropathic pain through a history and a neurological examination, sometimes with questionnaires designed to screen for nerve-related pain, and sometimes with nerve conduction studies or imaging.

What kinds of treatments are studied for Postherpetic Neuralgia?

Registered studies cover medicines, medical devices (such as nerve stimulators), procedures (such as nerve blocks or injections), physical and movement therapies, psychological approaches (such as cognitive behavioural therapy), education programs and digital tools. Being studied in a trial does not mean a treatment works or is approved. The interventions listed on this page come directly from the registry records.

How can I find Postherpetic Neuralgia clinical trials in Canada?

No registry record in this snapshot uses this exact term with a site in Canada. Related terms are linked below. Each trial page links to the official ClinicalTrials.gov record, which lists the study contacts. Recruiting status changes often, so check the registry, and talk to your doctor before joining a study.

Related conditions

Related interventions

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.